Singapore: Australian firm, Admedus, has achieved positive endpoint in its phase I trial of a therapeutic vaccine for H...
Singapore: Teva Parenteral Medicines has issued a voluntary recall of eight lots of Adrucil (fluorouracil injection) due...
Singapore: Biolife Science has signed a letter of intent with Swiss company Pevion Biotech for the manufacture of Biolif...
Singapore: China's Yisheng Biopharma, a biopharmaceutical company developing vaccines, has developed a new vaccine for t...
Singapore: Global biopharmaceutical company, Hospira, has initiated recall of one lot of Lidocaine HCI Injection, USP, 2...
Singapore: Sanofi Pasteur, the vaccines division of Sanofi, has announced that the Mexican authorities have granted mark...
Singapore: A number of European Union (EU) member states have halted the use, as a precautionary measure, of some anti-i...
Singapore: Pentamer Pharmaceuticals, US based biopharmaceutical company that has developed an ebola vaccine candidate, i...
Singapore: US-based PharmaJet entered into a collaboration with CSL to enable Afluria influenza vaccine to be delivered...
With a population of over 1.3 billion, China is poised for continued growth in the life sciences sector. There are sever...
Singapore: Australian biomedical company, Allied Healthcare, achieved successful results of its initial study of a novel...
Singapore: The Korean Ministry of Food and Drug Safety (MFDS) recently announced plans to support and nurture domestic v...
Singapore: Scientists from The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) ha...
Singapore: National Health Performance Authority in Australia has revealed that while Australia has high immunization ra...
The first-of-its-kind clinical trial to test the efficacy of a novel visceral leishmaniasis vaccine has started in India...
World's leading vaccine maker Sanofi Pasteur has launched a vaccine research and development project targeting the preve...
Singapore: BD (Becton, Dickinson and Company), a leading global medical technology company, has entered into a definitiv...
Bangalore: GlaxoSmithKline (GSK) and Biological E have signed an agreement to form a 50:50 joint venture (JV) for early ...
